Table 4.
Synovitis -Effusion | IPFP abnormality | Synovial proliferation score | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ACLOAS method | MOAKS method | Highest SI | Size | Knee | Popliteal cyst | |||||||
Coef. (95% CI) | P-valuea,b | Coef. (95% CI) | P-valuea,b | Coef. (95% CI) | P-valuea,b | Coef. (95% CI) | P-valuea,b | Coef. (95% CI) | P-valuea,b | Coef. (95% CI) | P-valuea,b | |
Average T2 value | 0.52 (0.15 – 0.89) |
0.01 | 0.62 (0.25 – 0.98) |
0.001 | 0.57 (0.27 – 0.88) |
<0.001 | 0.48 (0.07 – 0.90) |
0.02 | 0.45 (0.17 – 0.74) |
0.002 | 0.46 (0.16 – 0.76) |
0.003 |
WORMS max scoresc | ||||||||||||
Meniscus | 0.17 (− 0.03 – 0.38) |
0.09 | 0.28 (0.08 – 0.48) |
0.01 | 0.27 (0.10 – 0.43) |
0.002 | 0.15 (−0.08 – 0.37) |
0.20 | 0.22 (0.07 – 0.37) |
0.01 | 0.17 (0.01 – 0.34) |
0.04 |
Ligament | 0.08 (−0.06 – 0.22) |
0.27 | 0.14 (0.01 – 0.28) |
0.04 | 0.16 (0.04 – 0.28) |
0.01 | 0.18 (0.03 – 0.34) |
0.02 | 0.07 (−0.04 – 0.18) |
0.22 | −0.05 (−0.17 – 0.06) |
0.37 |
Cartilage | 0.73 (0.46 – 1.0) |
<0.001 | 0.47 (0.19 – 0.75) |
0.001 | 0.29 (0.06 – 0.53) |
0.01 | 0.24 (−0.08 – 0.56) |
0.14 | 0.38 (0.16 – 0.59) |
0.001 | 0.15 (−0.08 – 0.38) |
0.20 |
Bone marrow lesion | 0.23 (0.06 – 0.41) |
0.01 | 0.19 (0.01 – 0.36) |
0.04 | 0.15 (0.01 – 0.30) |
0.04 | 0.09 (−0.11 – 0.29) |
0.37 | 0.05 (−0.08 – 0.19) |
0.43 | 0.07 (−0.08 – 0.21) |
0.36 |
Subchondral bone cyst | 0.24 (0.06 – 0.41) |
0.01 | 0.32 (0.15 – 0.49) |
<0.001 | 0.05 (−0.09 – 0.20) |
0.48 | 0.04 (−0.16 – 0.24) |
0.69 | 0.11 (−0.03 – 0.24) |
0.12 | 0.11 (−0.03 – 0.25) |
0.13 |
Linear regression analysis adjusted for age, gender and race
Significant p-values are in bold (p-value < 0.05)
WORM = semi-quantitative whole organ MRI scores; WORMS max scores were defined as the maximum lesion score in any knee region
ACLOAS, Anterior Cruciate Ligament OsteoArthritis Score; MOAKS, MRI Osteoarthritis Knee Score; IPFP, InfraPatellar Fat Pad; SI, signal intensity; WOMAC, Western Ontario and McMasters Osteoarthritis Index